Condias GMBH
USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2020–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C25B (Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor).
The verdict
According to USPTO PatentsView, Condias ranks #45,834 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.
- #45,834
- of 49,997 US assignees by volume
- 14th percentile
- by Innovation Score (24.4/100)
- 13.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R45834 · Foreign Corporation #45,834 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,834/49,997
- PHOTO-FINISH Comprehensive…
- CPC-NARROW C25B · 8 areas
- INNOV-THIN 24.4/100
- CLAIMS-RICH 13.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2021 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Comprehensive Telemedicine (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Condias’s 24.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Condias
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Condias · this assignee 24
Condias · this assignee
24 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Condias's Innovation Score is 24.4/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Condias?
Each dot is one of Condias’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Condias’s own 13.6 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Condias's grants concentrate
Condias GMBH is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under C25B (Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor). Peak complete grant year is 2020 (3 grants) versus a trough of 2 in 2021. By volume, Condias sits between Comprehensive Telemedicine and Consensys Software Inc..
Who files at Condias's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Comprehensive Tel…
Comprehensive Telemedicine
5 patents
- Concealment Expre…
Concealment Express, LLC
5 patents
- Concentric Medical
Concentric Medical, Inc.
5 patents
- Concord III
Concord III, LLC
5 patents
- Coninvers
Coninvers GmbH
5 patents
- Connectm Technolo…
Connectm Technology Solutions, Inc.
5 patents
- Consarc
Consarc Corporation
5 patents
- Consensys Software
Consensys Software Inc.
5 patents
- Condias ◀
Condias GMBH
5 patents
What this shows Condias holds 5 patents at rank #45,622, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Condias
By rank, the assignees closest to #45,622 in granted patent volume.
- Comprehensive Telemedicine #45,618 · 5 patents
- Concealment Express, LLC #45,619 · 5 patents
- Concentric Medical, Inc. #45,620 · 5 patents
- Concord III, LLC #45,621 · 5 patents
- Coninvers GmbH #45,623 · 5 patents
- Connectm Technology Solutions, Inc. #45,624 · 5 patents
- Consarc Corporation #45,625 · 5 patents
- Consensys Software Inc. #45,626 · 5 patents
Leaders in C25B (Electrolytic OR Electrophoretic Processes FOR THE Product…)
Other assignees with the most granted patents in Condias's primary technology class.
Condias's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 14th percentile higher than 14% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 60.0% |
| 2021 | 2 | 40.0% |
Which technologies does Condias GMBH patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Condias GMBH's patent record in context - here's where to go next.
- Condias GMBH's lead technology class is C25B (Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor), 60% of its portfolio - see every assignee active in that class. Explore C25B
- Ranked #45,834 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Condias GMBH against Comprehensive Telemedicine, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.